hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance
Journal of Cancer Therapy
doi 10.4236/jct.2016.713097
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Scientific Research Publishing, Inc,